Job/Unit: O20299
/KAP1
Date: 21-06-12 16:02:40
Pages: 7
Synthesis of Glycosylated Eumelanin Building Blocks
mixture of thioglycosides (0.19 mmol of thioglycosyl units) were
dissolved under argon in acetonitrile (2.5 mL) (acetonitrile was
deoxygenated with a stream of argon for 15 min prior to use). To
the resulting solution was added NBS (25 mg, 0.15 mmol) under
argon, and the mixture was stirred under laboratory illumination
at the temperature indicated in Table 1. At the end of the reaction,
the mixture was diluted with CH2Cl2, and the organic phase was
washed with aqeous thiosulfate. The aqueous phase was re-ex-
tracted with CH2Cl2, and the combined organic phases were dried
and concentrated under vacuum to yield a residue that was purified
by silica gel flash chromatography (hexane/ethyl acetate).
5,6-Diacetoxyindol-3-yl 2,3,4-Tri-O-acetyl-1-thio-β-D-fucopyran-
oside (8): Rf = 0.43 (ethyl acetate/hexane, 7:3); [α]D = +83.5 (c =
0.8, CHCl3). 1H NMR (500 MHz, CDCl3): δ = 8.67 (br. s, 1 H.
NH), 7.55 (s, 1 H), 7.28 (d, J = 2.0 Hz, 1 H), 7.14 (s, 1 H), 5.15
(br. d, J = 3.0 Hz, 1 H, Fuc 4-H), 5.11 (t, J = 10.0 Hz, 1 H, Fuc
2-H), 5.00 (dd, J = 3.0, 9.5 Hz, 1 H, Fuc 3-H), 4.43 (d, J = 9.5 Hz,
1 H, Fuc 1-H), 3.70 (br. q, J = 6.5 Hz, 1 H, Fuc 5-H), 2.32 (ϫ2),
2.15, 1.95, 1.93 (5 s, 18 H, 6 COCH3), 1.13 (d, J = 6.5 Hz, 3 H,
Fuc 6-H3) ppm. 13C NMR (125 MHz, CDCl3): δ = 170.7, 170.1,
169.6, 169.2 (ϫ2, COCH3), 138.4, 136.8, 133.3, 132.9, 127.8, 114.0,
105.9, 101.7 (indole C atoms), 86.2 (Fuc C-1), 72.9, 72.5, 70.2, 67.3,
21.0, 20.7, 20.5; 16.3 (Fuc C-6) ppm. MALDI-MS: calcd. for [M
+ Na]+ 559.97; found 560.12. C24H27NO11S (537.54): calcd. C
53.63, H 5.06; found C 53.45, H, 5.00.
5,6-Diacetoxyindol-3-yl 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-galacto-
pyranoside (1): Rf = 0.40 (ethyl acetate/hexane, 3:2). [α]D = –70.7 (c
1
= 0.6, CHCl3). H NMR (400 MHz, CDCl3): δ = 8.81 (br. s, 1 H,
5,6-Diacetoxyindol-3-yl 2,3,4,6-Tetra-O-acetyl-β-
D-galacto-pyran-
NH), 7.51 (s, 1 H), 7.29 (d, J = 2.8 Hz, 1 H), 7.14 (s, 1 H), 5.28
(br. d, J = 2.8 Hz, 1 H, Gal 4-H), 5.07 (t, J = 10.0 Hz, 1 H, Gal
2-H), 4.98 (dd, J = 2.8, 10.0 Hz, 1 H, Gal 3-H), 4.44 (d, J =
10.0 Hz, 1 H, Gal 1-H), 4.10 (dd, J = 6.8, 10.8 Hz, 1 H, Gal 6a-
H), 3.97 (dd, J = 6.8, 11.2 Hz, 1 H, Gal 6b-H), 3.81 (br. t, J =
6.8 Hz, 1 H, Gal 5-H), 2.32, 2.31, 2.14, 2.01, 1.93, 1.85 (6 s, 18 H,
6 COCH3) ppm. 13C NMR (100 MHz, CDCl3): δ = 170.4, 170.3,
170.1, 169.5, 169.4 (ϫ2, COCH3), 138.1, 136.6, 133.5, 133.2, 127.8,
113.7, 105.9, 100.4 (indole Cs), 86.1 (Glc C-1), 74.1, 72.1, 67.1
(ϫ2), 61.6, 20.9, 20.7, 20.6, 20.5 (ϫ2), 20.2 ppm. MALDI-TOF
osyl-(1Ǟ4)-2,3,6-tri-O-acetyl-1-thio-β- -glucopyranoside (9): Rf =
D
1
0.43 (ethyl acetate/hexane, 4:1). [α]D = –76.5 (c = 1.0, CHCl3). H
NMR (500 MHz, CDCl3): δ = 8.61 (br. s, 1 H, NH), 7.50 (s, 1 H),
7.21 (d, J = 2.5 Hz, 1 H), 7.15 (s, 1 H), 5.29 (br. d, J = 3.0 Hz, 1
H, Gal 4-H), 5.14 (t, J = 9.0 Hz, 1 H, Glc 3-H), 5.05 (dd, J = 8.0,
10.5 Hz, 1 H, Gal 2-H), 4.89 (dd, J = 3.0, 10.0 Hz, 1 H, Gal 3-H),
4.75 (t, J = 10.0 Hz, 1 H, Glc 2-H), 4.42 (br. d, J = 11.5 Hz, 1 H,
Glc 6a-H), 4.40 (d, J = 10.0 Hz, 1 H, Glc 1-H), 4.35 (d, J = 8.0 Hz,
1 H, Gal 1-H), 4.10–4.00 (overlapped signals, 2 H, Gal 6-H2), 3.97
(dd, J = 4.0, 11.5 Hz, 1 H, Glc 6b-H), 3.78 (br. t, J = 7.0 Hz, 1 H,
Gal 5-H), 3.56–3.48 (m, 2 H, Glc 4-H and 5-H), 2.32 (ϫ2), 2.12
(ϫ2), 2.04, 2.01, 2.00, 1.99, 1.95 (5 s, 27 H, 9 COCH3) ppm. 13C
NMR (125 MHz, CDCl3): δ = 170.4 (ϫ2), 170.3, 170.1, 169.8.
169.7, 169.4, 169.2, 169.0 (COCH3), 138.5, 136.9, 133.7, 133.3,
128.4, 114.2, 105.9, 100.9 (indole C atoms and Gal C-1), 84.8 (Glc
C-1), 75.9, 74.1, 70.9, 70.5, 69.8, 69.0, 66.5, 62.2, 60.6, 60.4, 20.9,
20.8, 20.6, 20.5, 20.4 ppm. MALDI-MS: calcd. for [M + Na]+
906.60; found 906.81. C38H45NO21S (883.82): calcd. C 51.64, H
5.13; found C 51.80, H 5.05.
MS: calcd. for [M + Na]+ 617.90; found 618.13. C26H29NO13
(595.57): calcd. C 52.43, H 4.91; found C 52.25, H 4.95.
S
5,6-Diacetoxyindol-3-yl 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-glucopyr-
anoside (6): Rf = 0.40 (ethyl acetate/hexane, 3:2). [α]D = –70.8 (c =
0.5, CHCl3). 1H NMR (500 MHz, CDCl3): δ = 8.63 (br. s, 1 H,
NH), 7.49 (s, 1 H), 7.28 (d, J = 2.5 Hz, 1 H), 7.16 (s, 1 H), 5.17 (t,
J = 9.5 Hz, 1 H, Glc 3-H), 4.91 and 4.90 (overlapped t, J = 9.5,
10.0 Hz, 2 H, Glc 2-H and 4-H), 4.43 (d, J = 10.0 Hz, 1 H, Glc 1-
H), 4.15–4.05 (m, 2 H, Glc 6-H2), 3.65–3.60 (m, 1 H, Glc 5-H),
2.32, 2.31, 2.13, 1.99, 1.98, 1.96 (6 s, 18 H, 6 COCH3) ppm. 13C
NMR (125 MHz, CDCl3): δ = 170.7, 170.2, 169.4, 169.3, 169.2,
169.1 (COCH3), 138.5, 136.9, 133.4, 133.2, 128.6, 113.8, 105.9,
100.1 (indole C atoms), 85.3 (Glc C-1), 75.6, 74.2, 69.7, 68.0, 62.0,
20.8–20.5 ppm. MALDI-MS: calcd. for [M + Na]+ 618.13; found
617.97. C26H29NO13S (595.57): calcd. C 52.43, H 4.91; found: C
52.30, H 4.85.
5,6-Diacetoxyindol-3-yl 3,4,6-Tri-O-acetyl-2-deoxy-2acetamido-1-
thio-β-D-glucopyranoside (10): Rf = 0.30 (ethyl acetate). [α]D = –67.4
1
(c = 0.5, CHCl3). H NMR (500 MHz, CDCl3): δ = 9.04 (br. s, 1
H, NH), 7.46 (s, 1 H), 7.19 (d, J = 2.4 Hz, 1 H), 7.08 (s, 1 H), 6.08
(d, J = 9.2 Hz, 1 H, 2-NHAc), 5.18 (t, J = 9.6 Hz, 1 H, GlcNAc
3-H), 4.91 (t, J = 9.6 Hz, 1 H, GlcNAc 4-H), 4.56 (d, J = 10.0 Hz,
1 H, GlcNAc 1-H), 4.15–4.05 (m, 2 H, GlcNAc 6-H2), 3.86 (q, J
= 9.2 Hz, 1 H, GlcNAc 2-H), 3.65–3.55 (m, 1 H, Glc 5-H), 2.32,
2.31, 2.02 (ϫ2), 1.97 (ϫ2, 4 s, 18 H, 6 COCH3) ppm. 13C NMR
(125 MHz, CDCl3): δ = 170.8 (ϫ2), 170.5, 169.7, 169.5, 169.4
(COCH3), 138.2, 136.6, 133.2 (ϫ2), 127.9, 113.6, 106.2, 100.5 (in-
dole C atoms), 86.5 (GlcNAc C-1), 75.4, 73.8, 68.5, 62.3, 52.9 (C-
2), 23.2, 20.7–20.5 ppm. MALDI-MS: calcd. for [M + Na]+ 617.16;
found 617.27. C26H30N2O12S (594.59): calcd. C 52.52, H 5.09;
found C 52.30, H 4.95.
5,6-Diacetoxyindol-3-yl 2,3,4,6-Tetra-O-acetyl-1-thio-D-mannopyr-
anoside (7): Rf = 0.40 (ethyl acetate/hexane, 3:2). 1H NMR
(500 MHz, CDCl3): δ (signals of α-anomer) = 8.61 (br. s, 1 H, NH),
7.42 (s, 1 H), 7.30 (d, J = 2.5 Hz, 1 H), 7.16 (s, 1 H), 5.51 (dd, J =
1.5, 3.0 Hz, 1 H, Man 2-H), 5.40 (dd, J = 3.0, 9.5 Hz, 1 H, Man
3-H), 5.30 (t, J = 10.0 Hz, 1 H, Man 4-H), 5.11 (br. s, 1 H, Man
1-H), 4.50–4.58 (m, 1 H, Man 5-H), 4.28 (dd, J = 5.0, 12.0 Hz, 1
H, Man 6a-H), 4.08 (dd, J = 2.5, 12.0 Hz, 1 H, Man 6b-H), 2.31,
2.30, 2.09, 2.07, 2.05, 2.00 (6 s, 18 H, 6 COCH3) ppm; δ (significant
signals of the β-anomer) = 8.59 (br. s, 1 H, NH), 7.51 (s, 1 H), 7.24
(d, J = 2.5 Hz, 1 H), 7.16 (s, 1 H), 5.64 (d, J = 3.0 Hz, 1 H, Man
2-H), 5.27 (t, J = 10.0 Hz, 1 H, Man 4-H), 4.96 (dd, J = 3.5,
10.0 Hz, 1 H, Man 3-H), 4.59 (s, 1 H, Man 1-H), 3.45–3.55 (m, 1
H, Man 5-H), 2.32, 2.30, 2.12, 2.04, 2.00, 1.96 (6 s, 18 H, 6 COCH3)
ppm. 13C NMR (125 MHz, CDCl3): δ = 170.8, 170.7, 170.4, 170.1,
170.0, 169.8, 169.7, 169.6, 169.5, 169.4 (COCH3), 138.4 (ϫ2), 136.9
(ϫ2), 133.2 (ϫ2), 132.5 (ϫ2), 127.2, 126.7, 113.1, 112.3, 106.6,
106.4, 102.3, 101.4 (indole C atoms), 86.2, 85.8 (2 C-1), 76.2, 72.0,
70.6, 70.4, 69.6, 69.3, 66.5, 65.6, 62.6 (ϫ 2), 20.7–20.5 ppm.
MALDI-MS: calcd. for [M + Na]+ 618.13; found 617.92.
C26H29NO13S (595.57): calcd. C 52.43, H 4.91; found C 52.55, H
4.85.
Supporting Information (see footnote on the first page of this arti-
1
cle): Copies of the H and 13C NMR spectra of all products.
Acknowledgments
This work carried out in the frame of the Programmi di Ricerca di
Interesse Nazionale (PRIN) 2008 project (M. d’I.).
[1] a) M. d’Ischia, A. Napolitano, A. Pezzella, E. J. Land, C. A.
Ramsden, P. A. Riley, Adv. Heterocycl. Chem. 2005, 89, 1; b)
M. d’Ischia, A. Napolitano, A. Pezzella, Eur. J. Org. Chem.
2011, 5501.
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5